Search Results 101-110 of 15430 for infliximab

1. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of ABT-494 for the Induction of Symptomatic and Endoscopic Remission in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Immunomodulators or Anti-TNF Therapy - Mayo Clinic

   ... infliximab, adalimumab, or certolizumab pegol). Exclusion Criteria: Subjects with ulcerative colitis (UC), collagenous colitis or indeterminate colitis ...

2. A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD) - Mayo Clinic

   corticosteroids, immunomodulators (eg, AZA, 6-mercaptopurine, methotrexate), and/or TNF-α antagonist therapy (e.g., infliximab, adalimumab). This includes ...

3. A Study To Assess The Change In Disease Activity In Adult Participants With Moderate To Severe Ulcerative Colitis Treated With Risankizumab Compared To Vedolizumab - Mayo Clinic

   * Participant has received any targeted therapies (TaTs) for UC, including but not limited to infliximab, etanercept, adalimumab, natalizumab, golimumab ...

4. Baricitinib (oral route) - Side effects & dosage - Mayo Clinic

   Infliximab; Influenza Virus Vaccine, Live; Ixekizumab; Leflunomide; Measles Virus Vaccine, Live; Mumps Virus Vaccine, Live; Nitisinone; Poliovirus Vaccine, Live ...

5. Low Dose Oral Methotrexate in Pediatric Crohn's Disease Patients Initiating Anti-Tumor Necrosis Factor (Anti-TNF) Therapy - Mayo Clinic

   Pediatric Crohn's Disease (PCD) patients, < 21 years of age, ≥20 kg, initiating anti-TNF therapy with infliximab or adalimumab. Diagnosis of Crohn's ...

6. Publications - Michael C. Stephens, M.D. - Mayo Clinic

   Safety and steroid-sparing experience using infliximab for Crohn's disease at a pediatric inflammatory bowel disease center. Am J Gastroenterol. 2003 Jan ...

7. Ustekinumab-aekn (subcutaneous route) - Mayo Clinic

   Cyclosporine; Dengue Tetravalent Vaccine, Live; Ebola Zaire Vaccine, Live; Infliximab; Influenza Virus Vaccine, Live; Measles Virus Vaccine, Live; Mumps Virus ...

8. Certolizumab (subcutaneous route) - Side effects & dosage - Mayo Clinic

   Infliximab; Influenza Virus Vaccine, Live; Measles Virus Vaccine, Live; Mumps Virus Vaccine, Live; Natalizumab; Poliovirus Vaccine, Live; Rituximab; Rotavirus ...

9. Etanercept (subcutaneous route) - Side effects & dosage - Mayo Clinic

   Baricitinib; Cholera Vaccine, Live; Cyclophosphamide; Dengue Tetravalent Vaccine, Live; Infliximab; Influenza Virus Vaccine, Live; Measles Virus Vaccine, Live ...

10. Publications - Manreet Kaur, M.B.B.S., M.D. - Mayo Clinic

    Steroid-refractory ulcerative colitis—ciclosporin or infliximab? Nat Rev Gastroenterol Hepatol. 2013; 10(1):8-9. Wang C, Hanly EK, Wheeler LW, Kaur M ...